Morria Biopharmaceuticals Plc is a biopharmaceutical company focusing on the development of anti-inflammatory agents termed Multi-Functional Anti-Inflammatory Drugs. Morria is targeting three major inflammatory disease areas: Dermatology (contact dermatitis), Respiratory (allergic rhinitis and cystic fibrosis), Gastro-intestinal inflammatory (IBD).